Effect of paclitaxel content in the DHP107 oral formulation on oral bioavailability and antitumor activity

Title
Effect of paclitaxel content in the DHP107 oral formulation on oral bioavailability and antitumor activity
Authors
정혜선장유라고민경박예은홍정완이인현정혜진
Keywords
anticancer drug; oral; DHP107; physical property
Issue Date
2018-12
Publisher
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
Citation
VOL 48-192
Abstract
DHP107 is a novel lipid-based oral paclitaxel formulation for the treatment of various cancers. In the present study, to increase the treatment effect of DHP107, we aimed to improve this formulation. We optimized the paclitaxel content in DHP107 formulation, evaluated its antitumor activity, and compared its activity with that of the intravenous paclitaxel formulation, Taxol?, in various mouse cancer models. The oral bioavailability of paclitaxel increased dose-dependently up to 50  mg/kg. However, the paclitaxel absorption from the DHP107 formulations containing ≥1.5% (w/v) paclitaxel decreased with the increase in DHP107 dose as paclitaxel was crystallized when exposed to water. Therefore, the optimized DHP107 formulation containing 1% (w/v) paclitaxel was selected, and it exhibited similar antitumor activity as Taxol?. However, the DHP107 showed a better survival rate with low toxicity than that of Taxol?. The concentration of paclitaxel in the tumor tissues of mice in the DHP107 was also higher than that in Taxol?. The optimized DHP107 formulation might reduce the possible toxic effects of the formulation, with antitumor activities similar to those of intravenous paclitaxel Taxol?, by enhancing the distribution to tumor tissues. Furthermore, it might be beneficial to use DHP107 for patients with hypersensitivity reactions to intravenous Taxol?.
URI
http://pubs.kist.re.kr/handle/201004/69761
ISSN
1157-1489
Appears in Collections:
KIST Publication > Article
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE